Northwest Biotherapeutics appoints Pat Sarma as Class II director effective March 18, 2024

NORTHWEST BIOTHERAPEUTICS INC

Pat Sarma appointed as Class II director and to Audit, Compensation, and Conflicts Committees.
No arrangements or related-party transactions in connection with his appointment.
Compensation will be on same basis as other non-employee directors.
Appointment date: March 18, 2024.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Pat Sarma

Class II director

NWBO · NORTHWEST BIOTHERAPEUTICS INC

Effective: 2024-03-18
Filed: March 22, 2024, 7:59 PM ET

The Board appointed Pat Sarma as a Class II director on March 18, 2024, and also appointed him to the Audit, Compensation, and Conflicts Committees of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Pat Sarma was appointed as Class II director at NORTHWEST BIOTHERAPEUTICS INC.

Action: appointed
Role: Class II director

Exact text from the filing

The Board appointed Pat Sarma as a Class II director on March 18, 2024, and also appointed him to the Audit, Compensation, and Conflicts Committees of the Board.

View on SEC.gov

NORTHWEST BIOTHERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001104659-24-037901

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.